Malabsorption disorders : Patients with conditions like Crohns disease, celiac disease, or pernicious anemia that affect the absorption of nutrients may require more frequent injections, approximately every 4-8 weeks
The compound shows high enzymatic selectivity, preserves lean mass, and engages longevity-related pathways (e.g., SIRT1), but remains a nonFDA-approved research substance that is WADA-banned and should be used under medical guidance
All compounds at peak coordinated activity
Thaiss, C
However, its always important to consult a healthcare provider to ensure this treatment is appropriate
Our approach includes: Comprehensive wellness evaluation Detailed symptom and medical history review Lab-guided peptide selection Customized dosing and treatment protocols Ongoing safety and progress monitoring Integration with BHRT, IV therapy, weight-loss care, mental health support and nutrition Everything is designed to support your whole-body wellness, not just one symptom